tripelennamine has been researched along with Aura in 2 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KING, G | 1 |
| WEEKS, SD | 1 |
| Shovalter, CV | 1 |
2 other studies available for tripelennamine and Aura
| Article | Year |
|---|---|
PYRIBENZAMINE ACTIVATION OF THE ELECTROENCEPHALOGRAM.
Topics: Adolescent; Electroencephalography; Epilepsy; Epilepsy, Absence; Epilepsy, Temporal Lobe; Epilepsy, | 1965 |
Abuse of pentazocine and tripelennamine.
Topics: Diagnosis, Differential; Drug Synergism; Epilepsy; Humans; Pentazocine; Substance-Related Disorders; | 1978 |